Want to join the conversation?
$STJ and Thoratec today announced that the BoD of both companies have unanimously approved a definitive agreement under which STJ will acquire all of the outstanding shares of Thoratec for $63.50 per share in a cash transaction valued at approx. $3.4Bil, net of cash acquired.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.